0001104659-23-078088.txt : 20230705
0001104659-23-078088.hdr.sgml : 20230705
20230705160728
ACCESSION NUMBER: 0001104659-23-078088
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230630
FILED AS OF DATE: 20230705
DATE AS OF CHANGE: 20230705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Herskowitz Neil
CENTRAL INDEX KEY: 0001298246
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38114
FILM NUMBER: 231068851
MAIL ADDRESS:
STREET 1: 2109 BROADWAY, SUITE 206
CITY: NEW YORK
STATE: NY
ZIP: 10023
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVENUE THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001644963
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474113275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1111 KANE CONCOURSE
STREET 2: SUITE 301
CITY: BAY HARBOR ISLANDS
STATE: FL
ZIP: 33154
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 1111 KANE CONCOURSE
STREET 2: SUITE 301
CITY: BAY HARBOR ISLANDS
STATE: FL
ZIP: 33154
4
1
tm2320488d1_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-06-30
0
0001644963
AVENUE THERAPEUTICS, INC.
ATXI
0001298246
Herskowitz Neil
1111 KANE CONCOURSE, SUITE 301
BAY HARBOR ISLANDS
FL
33154
1
0
0
0
0
Employee stock option (right to buy)
1.14
2023-06-30
4
A
0
100000
0
A
2033-06-30
Common Stock
100000
100000
D
The option vests in accordance with the following schedule: (i) one-third of the shares subject to the option vest on January 1, 2024; (ii) one-third of the shares subject to the option vest on January 1, 2025; and (iii) one-third of the shares subject to the option vest on January 1, 2026.
Effective September 22, 2022, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.
/s/ Neil Herskowitz
2023-07-05